Forum Discussion
wendy_h67
8 years agoMember
Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
brightspace
8 years agoMember
Hi Wendy..yep it is a bloody shame it is called fence sitting..the rigorous conditions for approval seem to be working against us majority of female metastatic bc patients ..they have approved wonder drugs for prostate and skin cancers BUT not us
AND there will be conditions that prevent us from receiving these drugs..
Some trials here in australia stated mainly you had to have had no prior treatment.No chemo...or AI within One month.these would preclude many of us .This appears very biased when women in the US have been given these wonder drugs
AND there will be conditions that prevent us from receiving these drugs..
Some trials here in australia stated mainly you had to have had no prior treatment.No chemo...or AI within One month.these would preclude many of us .This appears very biased when women in the US have been given these wonder drugs